
Ethyl 4-phenylacetoacetate | CAS:718-08-1
Ethyl 4-phenylacetoacetate
- Name:Ethyl 4-phenylacetoacetate
- CAS:718-08-1
- Synonyms:4-Phenyl-3-oxobutanoic acid ethyl ester
- Molecular Formula:C12H14O3
- Molecular Weight:206.24
- EINESC:
Description
Properties
Boiling point | 290 ºC |
---|---|
Flash point | 124 ºC |
Density | 1.091 |
Refractive index | 1.054-1.059 |
Safety
没有数据 | 没有数据 |
---|
SDS
Source | SDS/MSDS Samples |
---|---|
Oakwood | View & Download |
Matrix | View & Download |
Synthetic Route
Name | CAS |
---|
More
Articles
Peer-Reviewed Papers
[Pharmacological and clinical properties of didanosine (VIDEX), a nucleoside reverse transcriptase inhibitor].Masahiko Okiyama et al.Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 120(2), 115-122 (2002-08-22)
Update on didanosine.David A Cooper Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002), 1(1), 15-25 (2003-08-29)
Toxic interaction of didanosine and acetaminophen leading to severe hepatitis and pancreatitis: a case report and review of the literature.J C Lederman et al.The American journal of gastroenterology, 96(12), 3474-3475 (2002-01-05)
Didanosine: an updated review of its use in HIV infection.C M Perry et al.Drugs, 58(6), 1099-1135 (2000-01-29)
Target cell availability and the successful suppression of HIV by hydroxyurea and didanosine.R J De Boer et al.AIDS (London, England), 12(13), 1567-1570 (1998-10-09)
Noncirrhotic portal hypertension associated with didanosine: a case report and literature review.Hui-Min Chang et al.Japanese journal of infectious diseases, 65(1), 61-65 (2012-01-26)
The role of didanosine in the management of HIV-1 infection.B G Gazzard et al.Antiviral therapy, 2(3), 135-147 (1997-07-01)
Severe toxicity associated with the combination of tenofovir and didanosine: case report and review.M Masiá et al.International journal of STD & AIDS, 16(9), 646-648 (2005-09-24)
Zidovudine (AZT) versus AZT plus didanosine (ddI) versus AZT plus zalcitabine (ddC) in HIV infected adults.J Darbyshire et al.The Cochrane database of systematic reviews, (3)(3), CD002038-CD002038 (2000-07-25)
Effect of tenofovir on didanosine absorption in patients with HIV.Patricia Pecora Fulco et al.The Annals of pharmacotherapy, 37(9), 1325-1328 (2003-08-19)
Peripheral neuropathy in HIV: an analysis of evidence-based approaches.Patrice K Nicholas et al.The Journal of the Association of Nurses in AIDS Care : JANAC, 25(4), 318-329 (2014-04-05)
Didanosine. An update on its antiviral activity, pharmacokinetic properties and therapeutic efficacy in the management of HIV disease.C M Perry et al.Drugs, 52(6), 928-962 (1996-12-01)
Didanosine once daily: an overview.M Youle Antiviral therapy, 3 Suppl 4, 35-37 (2000-03-21)
Tenofovir and didanosine: a dangerous liaison.Laura Waters et al.The AIDS reader, 15(8), 403-406 (2005-08-23)
Systematic review of combination antiretroviral therapy with didanosine plus hydroxyurea: a partial solution to Africa's HIV/AIDS problem?I Sanne et al.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 5(1), 43-48 (2001-04-04)
Didanosine once daily: potential for expanded use.R B Pollard AIDS (London, England), 14(16), 2421-2428 (2000-01-11)
Didanosine enteric-coated capsule: current role in patients with HIV-1 infection.Santiago Moreno et al.Drugs, 67(10), 1441-1462 (2007-06-30)
Artemether-lumefantrine co-administration with antiretrovirals: population pharmacokinetics and dosing implications.Richard M Hoglund et al.British journal of clinical pharmacology, 79(4), 636-649 (2014-10-10)
Didanosine, lamivudine-emtricitabine and efavirenz as initial therapy in naive patients.Rosario Palacios et al.Expert review of anti-infective therapy, 4(6), 965-971 (2006-12-22)
Bioretrosynthetic construction of a didanosine biosynthetic pathway.William R Birmingham et al.Nature chemical biology, 10(5), 392-399 (2014-03-25)
Overview of the preclinical development of an antiretroviral drug, 2',3'-dideoxyinosine.J J McGowan et al.Reviews of infectious diseases, 12 Suppl 5, S513-S520 (1990-07-01)
Fanconi syndrome and nephrogenic diabetes insipidus associated with didanosine therapy in HIV infection: a case report and literature review.Géraldine D'Ythurbide et al.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 22(12), 3656-3659 (2007-10-02)
Zidovudine (AZT) versus AZT plus didanosine (ddI) versus AZT plus zalcitabine (ddC) in HIV infected adults.J Darbyshire et al.The Cochrane database of systematic reviews, (2)(2), CD002038-CD002038 (2000-05-05)
Tenofovir plus didanosine as Nrti backbone in HIV-infected subjects.Marco Bongiovanni et al.Current medicinal chemistry, 13(23), 2789-2793 (2006-11-01)
Down-regulation of mitochondrial thymidine kinase 2 and deoxyguanosine kinase by didanosine: implication for mitochondrial toxicities of anti-HIV nucleoside analogs.Sun R, Eriksson S, and Wang L Biochemical and Biophysical Research Communications, 450(2), 1021-1026 (2014)
Remarks
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).
Name | CAS |
---|

Related Products
Related News
Question
Hot Tags
Inquiry
Fill in related informations ;please!
- Please fill in product name !
- CAS
- Please fill in your company information correctly!
- Please fill in liaison information correctly!
- Please fill in your telephone number correctly!
- Please fill in your email correctly!
- Please describe the problem of products!